These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11287691)
1. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. van Benthem BH; Spaargaren J; van Den Hoek JA; Merks J; Coutinho RA; Prins M; Sex Transm Infect; 2001 Apr; 77(2):120-4. PubMed ID: 11287691 [TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. Ameli N; Bacchetti P; Morrow RA; Hessol NA; Wilkin T; Young M; Cohen M; Minkoff H; Gange SJ; Greenblatt RM AIDS; 2006 Apr; 20(7):1051-8. PubMed ID: 16603858 [TBL] [Abstract][Full Text] [Related]
3. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. Schacker T; Zeh J; Hu HL; Hill E; Corey L J Infect Dis; 1998 Dec; 178(6):1616-22. PubMed ID: 9815213 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of herpes simplex virus (HSV)- type 2 co-infection among HIV-positive women in Ukraine, but no increased HIV mother-to-child transmission risk. Aebi-Popp K; Bailey H; Malyuta R; Volokha A; Thorne C; BMC Pregnancy Childbirth; 2016 Apr; 16():94. PubMed ID: 27121953 [TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada. Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690 [TBL] [Abstract][Full Text] [Related]
6. Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho. Rabenau HF; Lennemann T; Kircher C; Gürtler L; Staszewski S; Preiser W; McPherson P; Allwinn R; Doerr HW Sex Transm Dis; 2010 Jul; 37(7):454-9. PubMed ID: 20531031 [TBL] [Abstract][Full Text] [Related]
7. Seroepidemiological study of herpes simplex virus type 2 in patients with the acquired immunodeficiency syndrome in the city of Niterói, Rio de Janeiro, Brazil. Santos FC; de Oliveira SA; Setúbal S; Camacho LA; Faillace T; Leite JP; Velarde LG; Mem Inst Oswaldo Cruz; 2006 May; 101(3):315-9. PubMed ID: 16862329 [TBL] [Abstract][Full Text] [Related]
8. Association of herpes simplex virus type 2 with the human immunodeficiency virus among urban women in Zimbabwe. Mbizvo EM; Msuya Sia E; Stray-Pedersen B; Chirenje MZ; Munjoma M; Hussain A Int J STD AIDS; 2002 May; 13(5):343-8. PubMed ID: 11972939 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial. Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700 [TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania. Mmbaga EJ; Leyna GH; Stray-Pedersen B; Klepp KI East Afr J Public Health; 2011 Mar; 8(1):28-32. PubMed ID: 22066279 [TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women. Roxby AC; Drake AL; John-Stewart G; Brown ER; Matemo D; Otieno PA; Farquhar C PLoS One; 2011; 6(5):e19947. PubMed ID: 21637835 [TBL] [Abstract][Full Text] [Related]
12. Age-disparate partnerships and HSV-2 among adolescent girls and young women in South Africa: implications for HIV infection risk. Maughan-Brown B; George G; Beckett S; Evans M; Lewis L; Cawood C; Khanyile D; Kharsany ABM Sex Transm Infect; 2019 Sep; 95(6):443-448. PubMed ID: 30737260 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study. Balaeva T; Grjibovski AM; Sidorenkov O; Samodova O; Firsova N; Sannikov A; Klouman E BMC Infect Dis; 2016 Oct; 16(1):616. PubMed ID: 27793121 [TBL] [Abstract][Full Text] [Related]
14. Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. Sudenga SL; Kempf MC; McGwin G; Wilson CM; Hook EW; Shrestha S Sex Transm Dis; 2012 Apr; 39(4):300-5. PubMed ID: 22421698 [TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons. Ramaswamy M; Sabin C; McDonald C; Smith M; Taylor C; Geretti AM Sex Transm Dis; 2006 Feb; 33(2):96-101. PubMed ID: 16432480 [TBL] [Abstract][Full Text] [Related]
16. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. Weiss HA; Buvé A; Robinson NJ; Van Dyck E; Kahindo M; Anagonou S; Musonda R; Zekeng L; Morison L; Caraël M; Laga M; Hayes RJ; AIDS; 2001 Aug; 15 Suppl 4():S97-108. PubMed ID: 11686471 [TBL] [Abstract][Full Text] [Related]
17. Detection of HSV-2 in genital ulcers from STD patients in Dar es Salaam, Tanzania. Mwansasu A; Mwakagile D; Haarr L; Langeland N J Clin Virol; 2002 Apr; 24(3):183-92. PubMed ID: 11856619 [TBL] [Abstract][Full Text] [Related]
18. Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department. Patel EU; Laeyendecker O; Hsieh YH; Rothman RE; Kelen GD; Quinn TC J Clin Virol; 2016 Jul; 80():93-7. PubMed ID: 27232485 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of HSV-1 and HSV-2 in Barbados. Levett PN Med Microbiol Immunol; 2005 Jan; 194(1-2):105-7. PubMed ID: 15156399 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. Watson-Jones D; Weiss HA; Rusizoka M; Baisley K; Mugeye K; Changalucha J; Everett D; Balira R; Knight L; Ross D; Hayes RJ J Acquir Immune Defic Syndr; 2007 Dec; 46(5):631-42. PubMed ID: 18043318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]